Zyban: Uses, Dosage & Safety Information

Zyban

Zyban

Zyban

Bupropion hydrochloride
Former GlaxoSmithKline name for a twice-daily slow-release pill used to help adults stop smoking, no longer marketed, so prescriptions bearing it are filled with copies from other makers. Start a week before the quit day; seizures and mood changes are the key risks.
  • ActiveIngredient: Bupropion hydrochloride
  • DosageForm: Sustained-release tablet
  • Dosage: 150 mg
  • Indications: Aid to smoking cessation
  • Manufacturer: Multiple manufacturers
  • Storage: 20–25°C (68–77°F)
  • Drug Status: Discontinued

What is Zyban?

Zyban was GlaxoSmithKline’s bupropion sustained-release tablet approved in May 1997 as an aid to stopping smoking; the brand is discontinued, so a Zyban prescription today is filled with generic bupropion SR labelled for smoking cessation. It contains the same active ingredient as Wellbutrin SR and must never be combined with it; seizures and neuropsychiatric changes are its key risks.1

Brand discontinued; generic bupropion SR for smoking cessation available
Zyban (NDA 020711, approved May 14, 1997) is listed as discontinued, with an FDA determination that this was not for safety or effectiveness reasons; generic bupropion SR tablets labelled for smoking cessation remain available.2

Approved products and generic therapeutic-equivalence ratings are listed in the FDA Orange Book.3

Efficacy as a smoking-cessation aid was shown in 3 placebo-controlled trials in 1,940 non-depressed chronic smokers who also received individual counselling.1

In the dose-response trial, 36% of smokers on the usual dose had quit for the last 4 weeks of a 7-week course, compared with 17% on placebo.

Quit rates also rose on placebo in these counselling-supported trials, showing that the tablets add to, rather than replace, behavioural support.

It may be used together with a nicotine patch, and the most common reactions include insomnia, rhinitis, dry mouth, dizziness and anxiety.

Although not indicated for depression, it contains the same active ingredient as the Wellbutrin antidepressants and carries the same antidepressant suicidality warning.

How to Take Zyban

Set a quit day

Pick a quit date and start the tablets about a week before it.1

Two doses a day

After the first three days, take one tablet twice a day, at least 8 hours apart.

Swallow whole

Swallow the tablets whole; do not crush, divide or chew them.

Never double up

If you miss a dose, skip it rather than taking two together.

Not with Wellbutrin

Do not take it together with any other bupropion medicine.

Mood changes

Stop and contact your doctor about agitation, hostility, depression or unusual thoughts.

Blood pressure

Have your blood pressure checked, especially if you also use a nicotine patch.

Seizures

Seek urgent care for a seizure and do not restart.

MAOIs

Never take it within 14 days of an MAOI.

Rash

Seek urgent care for rash with swelling or trouble breathing.

Eye pain

Report eye pain, vision changes or eye redness straight away.

Keep counselling

Keep using counselling or a support programme alongside the tablets.

What Are the Side Effects of Zyban?

In the dose-response smoking-cessation trial, insomnia and dry mouth were the most common reactions above placebo, and skin reactions such as itching and rash also appeared.

Bupropion SR vs Placebo: Smokers
FrequencyEffectNotes
Very common — 31% (placebo 21%)InsomniaDose-response trial
Very common — 11% (placebo 5%)Dry mouthDose-response trial
Common — 8% (placebo 7%)DizzinessDose-response trial
Common — 4% (placebo 3%)ArthralgiaDose-response trial
Common — 3% (placebo <1%)Itching, rashDose-response trial
Common — 2% (placebo 0%)Bronchitis, dry skinDose-response trial

Source: 1

Seek immediate medical attention if:
  • A seizure, even a brief one
  • Severe agitation, hostility, depression or thoughts of suicide
  • Very high blood pressure or severe headache
  • Rash with fever, swelling or trouble breathing
Clinical details

The dose-response trial compared 461 smokers on bupropion SR with 150 on placebo.

What is Zyban Used For?

A prescription for Zyban is filled with bupropion hydrochloride sustained-release tablets labelled as an aid to smoking cessation treatment.1

Start before the quit day

Dosing begins about a week before the chosen quit day while the person is still smoking, once daily for three days and then twice daily with the doses at least 8 hours apart.

How long to continue

Treatment usually lasts 7 to 12 weeks; if someone has not stopped smoking by then, a quit is unlikely during that attempt, so the plan is reassessed.

With a nicotine patch

It may be combined with a nicotine transdermal system, in which case blood pressure is monitored because both can raise it.

Seizure precautions

Seizure risk is dose-related, so the dose is increased gradually and kept within the labelled limit, and treatment stops for good after a seizure.

Liver and kidney

In moderate to severe hepatic impairment, dosing drops to every other day, and in kidney impairment a lower dose or frequency is considered.

Children

Safety and effectiveness of bupropion SR for smoking cessation have not been established in people under 18.

Neuropsychiatric effects

Mood changes, psychosis and other neuropsychiatric reactions have been reported, and patients are told to contact a healthcare provider promptly if they occur.

Interactions Alcohol:

Unsafe
Minimise alcohol and never stop heavy drinking abruptly while on bupropion because of seizure risk.

Interactions Other Medications:

Use with caution
MAOIs and other bupropion products are contraindicated; nicotine patches need blood pressure checks.

Special Groups Pregnancy:

Consult your doctor
Discuss stopping smoking and bupropion use in pregnancy with your doctor.

Special Groups Breastfeeding:

Consult your doctor
Discuss breastfeeding during bupropion treatment with your doctor.

Special Groups Elderly:

Use with caution
Older adults may need lower doses because of reduced kidney function.

Special Groups Children:

Unsafe
Safety and effectiveness under age 18 have not been established for smoking cessation.

Effects on Activities Driving:

Use with caution
Bupropion may affect judgment or coordination; check your response before driving.

Effects on Activities Operating Machinery:

Use with caution
Avoid hazardous machinery until you know how bupropion affects you.

A discontinued smoking-cessation brand

Zyban is discontinued, so its name now points to generic bupropion SR tablets labelled for smoking cessation.2

Counselling is part of the treatment

The trials that showed benefit combined bupropion with individual smoking-cessation counselling, and quit rates also rose on placebo.1

Generic quality

Generic bupropion SR tablets must contain the same active ingredient and be bioequivalent to their reference product.4

Where it comes from

Bupropion is prescription-only in the US; the FDA’s BeSafeRx guidance lists four signs of a lawful pharmacy website.5

Critical Warnings for Zyban Use

Contraindications

Bupropion SR for smoking cessation is contraindicated with a seizure disorder, current or past bulimia or anorexia nervosa, abrupt withdrawal from alcohol or sedatives, MAOI use, and other bupropion products.1

Neuropsychiatric reactions

Mood changes, psychosis and other neuropsychiatric reactions have been reported in people using bupropion to quit smoking.

Suicidality

Antidepressants increased suicidal thoughts in children, adolescents and young adults, and bupropion shares that labelling.

Seizure

Seizure risk is dose-related and is minimised by gradual titration and a fixed daily limit.

Hypertension

Blood pressure can rise, particularly with nicotine replacement, so it is monitored before and during treatment.

See Interactions for the full list of drug combinations.

Dosage

Zyban Products
FormulationActive IngredientsClinical Note
ZybanZybanDiscontinued
Generic bupropion SR (smoking cessation)Bupropion SR150 mg tablets
Days 1–3Bupropion SR150 mg once daily
From day 4Bupropion SR150 mg twice daily, at least 8 hours apart
DurationBupropion SR7 to 12 weeks
Kidney: impairmentBupropion SRConsider reduced dose or frequency
Liver: moderate to severe impairmentBupropion SR150 mg every other day

Source: 1

Exceeding the dose
Overdoses of up to 30 grams or more of bupropion have been reported, with seizures in about one-third of cases and other serious effects such as hallucinations and loss of consciousness.1

Marketed strengths and their labelers are listed in the FDA National Drug Code Directory.6

What Does Zyban Interact With?

Interactions by Severity
Interacting SubstanceEffect and RiskSeverityDocumentation
MAOIs, linezolid, IV methylene blueHypertensive reactions; contraindicatedMajorGood — labelled
Drugs that lower seizure thresholdHigher seizure riskMajorGood — labelled
Nicotine transdermal systemPossible blood pressure increase; monitorModerateGood — labelled
CYP2D6 substratesHigher levels of those drugsModerateGood — labelled

Source: 1

No. Zyban (NDA 020711), approved in May 1997, is discontinued, and the FDA recorded that this was not for safety or effectiveness reasons. A Zyban prescription is filled with generic bupropion SR tablets labelled as an aid to smoking cessation, at the same 150 mg strength.
Bupropion SR, the medicine dispensed for Zyban, roughly doubled quit rates in its key trial. In that dose-response trial, 36% of smokers on the usual dose had not smoked for the final 4 weeks of a 7-week course. That compared with 17% on placebo, and all participants also received counselling. Results improve when tablets are combined with a quit plan and support.
Start bupropion SR about one week before your quit day, while you are still smoking, because steady blood levels take about a week. Take 150 mg once daily for 3 days, then 150 mg twice daily at least 8 hours apart, usually for 7 to 12 weeks.
Yes. Bupropion SR may be used with a nicotine transdermal system, but blood pressure should be checked before and during treatment because the combination can raise it. Tell your doctor if you get severe headaches or feel unwell after starting both together. Your pharmacist can help plan this.
Zyban contained bupropion, the same active ingredient as Wellbutrin SR and Wellbutrin XL, but it was approved for smoking cessation rather than depression. Never take two bupropion products together, because the combined dose raises seizure risk. Tell your doctor about all 3 brand names if prescribed any.

Evidence scope

What we know
  • Zyban was approved in May 1997 and is now discontinued.
  • 36% quit versus 17% on placebo over the last 4 weeks of a 7-week course.
  • Treatment starts about a week before the quit day.
  • Insomnia affected 31% versus 21% on placebo.
What remains uncertain
  • Long-term abstinence beyond the trial follow-up periods for each individual.
  • Safety and effectiveness in people under 18.
  • Why the Zyban brand left the market beyond the FDA note that it was not for safety reasons.

Source: 1

What has been reported to the FDA

Reports to the FDA naming bupropion hydrochloride, including Zyban, are summarised on the Wellbutrin SR page.7

Who was this medicine studied in?

Efficacy rests on 3 placebo-controlled trials in 1,940 non-depressed smokers, with 461 patients on bupropion in the dose-response safety data.1

Who this is and is not appropriate for

Not for people with seizure disorders, eating disorders, abrupt withdrawal from alcohol or sedatives, MAOI use, or already taking another bupropion product.

Adult smokers motivated to quit who will set a quit date and combine tablets with counselling.

Where to report and verify

Routing to Official Registries
What you needWhere to go
Report a side effectFDA MedWatch
Pregnancy-specific dataMotherToBaby
Full prescribing informationDailyMed
Verify a pharmacy websiteFDA BeSafeRx · LegitScript

References

  1. FDA label, Bupropion Hydrochloride Extended-Release Tablets USP (SR) for smoking cessation (Dr. Reddy’s; ANDA 206122)
    Revised 2025-10 · Accessed 2026-10-26
    Used for: indication, dosing around the quit day, contraindications, warnings incl. neuropsychiatric and seizure, adverse reactions, interactions, overdose, clinical studies.
    dailymed.nlm.nih.gov — bupropion SR SPL
  2. Drugs@FDA
    Record accessed 2026-10-26
    Used for: application and marketing status.
    accessdata.fda.gov — Drugs@FDA
  3. FDA Orange Book
    Accessed 2026-10-26
    Used for: reference and generic listings.
    accessdata.fda.gov — Orange Book
  4. FDA — Generic Drugs: Questions & Answers
    Accessed 2026-10-26
    Used for: requirements for generic equivalence (same active ingredient, strength, bioequivalence).
    fda.gov — Generic Drugs Q&A
  5. FDA BeSafeRx — signs of a safe pharmacy website (flyer)
    Accessed 2026-10-26
    Used for: four signs of a lawful pharmacy website.
    fda.gov — BeSafeRx
  6. FDA National Drug Code Directory
    Directory accessed 2026-10-26
    Used for: marketed products and strengths.
    accessdata.fda.gov — NDC Directory
  7. FDA Adverse Event Reporting System (openFDA)
    Data cut 2026-07-30 · Accessed 2026-10-26
    Used for: report totals and the ten most frequent terms.
    open.fda.gov — drug adverse event API

How this page was sourced

Clinical facts come from a current FDA-approved generic bupropion SR label for smoking cessation (October 2025).

Brand history comes from Drugs@FDA; the report summary is on the Wellbutrin SR page.

Disclaimer: The information on this site is provided for informational purposes only and is not medical advice. It does not replace professional medical consultation, diagnosis, or treatment. Do not self-medicate based on the information presented on this site. Always consult with a doctor or other qualified healthcare professional before making any decisions about your health.